ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer

HATA, Nanako

doi:10.1038/s41598-023-29397-z

ID	67762
Title Alternative	ADAR1は大腸癌肝転移切除後の残肝再発の有望なリスク層別化バイオマーカーである
FullText URL	K0007089_abstract_review.pdf 192 KB K0007089_fulltext.pdf 1.48 MB K0007089_summary.pdf 566 KB
Author	HATA, Nanako Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Note	岡山大学審査学位論文 Hata, N., Shigeyasu, K., Umeda, Y. et al. ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer. Sci Rep 13, 2078 (2023). https://doi.org/10.1038/s41598-023-29397-z
Published Date	2024-09-25
Content Type	Thesis or Dissertation
Grant Number	甲第7089号
Granted Date	2024-09-25
Thesis Type	Doctor of Philosophy in Medical Science
Grantor	岡山大学
Thesis FullText	Thesis or Dissertation (See FullText URL)
Related Url	isVersionOf https://doi.org/10.1038/s41598-023-29397-z
language	English
File Version	ETD
Grant ID	15301甲第7089号
PubMed ID	36747029
Copyright Holders	© The Author(s) 2023
DOI	10.1038/s41598-023-29397-z
License	http://creativecommons.org/licenses/by/4.0/